title: Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress.
abstract: Diabetes is characterized by the existence of a thrombosis-prone condition, possibly related to hyperglycemia. However, the mechanism linking hyperglycemia to the activation of the coagulation cascade is still unclear. It has been recently suggested that diabetes is accompanied by increased oxidative stress. In this work, the possibility that oxidative stress may be involved in the hyperglycemia-induced coagulation activation has been evaluated. Prothrombin fragment 1 + 2 (F1 + 2), which represents a reliable marker of the amount of thrombin released in the circulation, has been chosen for studying thrombin formation in vivo. In nine type II diabetic patients and in seven healthy control subjects, matched for age and body mass index, three different experiments were performed: oral glucose tolerance test (OGTT), intravenous antioxidant glutathione (GSH) administration for 2 h, and OGTT plus intravenous GSH administration. Samples were drawn at -15 min and every 30 min from 0 to 180 min. During the OGTT, F1 + 2 significantly increased in both diabetic and healthy subjects. GSH administration during OGTT normalized this phenomenon. GSH administration alone significantly decreased F1 + 2 in diabetic patients, while no effect was observed in the normal subjects. These data suggest that hyperglycemia may induce thrombin activation, possibly inducing an oxidative stress, and that antioxidant GSH may counterbalance this effect.
authors.affiliation: Department of Clinical and Experimental Pathology and Medicine, University of Udine, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Ceriello
authors.forename: R
authors.initials: R
authors.lastname: Giacomello
authors.forename: G
authors.initials: G
authors.lastname: Stel
authors.forename: E
authors.initials: E
authors.lastname: Motz
authors.forename: C
authors.initials: C
authors.lastname: Taboga
authors.forename: L
authors.initials: L
authors.lastname: Tonutti
authors.forename: M
authors.initials: M
authors.lastname: Pirisi
authors.forename: E
authors.initials: E
authors.lastname: Falleti
authors.forename: E
authors.initials: E
authors.lastname: Bartoli
mesh_terms: D000368:Aged; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000503:physiopathology*; D005260:Female; D005951:Glucose Tolerance Test; D005978:Glutathione / Q000494:pharmacology; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology*; D008297:Male; D018384:Oxidative Stress; D012016:Reference Values; D013917:Thrombin / Q000096:biosynthesis* / Q000378:metabolism
chemical_list: D001786:Blood Glucose; D013917:Thrombin; D005978:Glutathione